首页 | 本学科首页   官方微博 | 高级检索  
     

选择性肝动脉化疗药物灌注及栓塞治疗肝转移癌
引用本文:温树伟,党之俊,张晓前,翟守仁. 选择性肝动脉化疗药物灌注及栓塞治疗肝转移癌[J]. 实用医学影像杂志, 2001, 2(3): 162-163,167
作者姓名:温树伟  党之俊  张晓前  翟守仁
作者单位:山西省肿瘤医院,太原市,030013
摘    要:目的 探讨选择性肝动脉化疗药物灌注及栓塞治疗肝转移癌的价值。材料与方法对122例失去手术机会的肝转移癌患者,采用经股动脉穿刺,选择性肝动脉插管灌注化疗药物(ADM,MMC,CDDP,5-FU),并用ADM及碘化油乳化后检塞肝动脉。结果近期疗效以CT检查结果作为评价标准,总有效率为54%(66/122),平均生存期22.2个月。0.5、1、2、3年生存率分别是98.3%、80.4%、40.9%、10.6%。结论经肝动脉化疗药物灌注及栓塞治疗是失去手术机会的肝转移癌患者的一种安全、有效的姑息性治疗方法,其不仅能提高疗效,而且能改善患者的生活质量。

关 键 词:肝动脉 灌注化疗 动脉栓塞 肝转移肿瘤
文章编号:1009-6817(2001)03-0162-03

Selective hepatic arterial infusion chemotherapy and embolization in the treatment of liver metastases
Wen Shuwei,Dang Zhijun,Zhang Xiaoqian,et al.. Selective hepatic arterial infusion chemotherapy and embolization in the treatment of liver metastases[J]. Journal of Practical Medical Imaging, 2001, 2(3): 162-163,167
Authors:Wen Shuwei  Dang Zhijun  Zhang Xiaoqian  et al.
Affiliation:Wen Shuwei,Dang Zhijun,Zhang Xiaoqian,et al.Department of Diagnostic Radiology,Shanxi Provincial Tumor Hospital,Taiyuan 030013
Abstract:Objective To evaluate the efficacy of selectiv e hepatic arterial infusion chemoth erapy and embolization in the treatm ent of unresectable liver metastases.Methods Percutaneous selective hepatic arterial infusion chemotherapy(Abriamycin,mitomycin,Cisplatin,5-fluorouracil)and embolization(mixture of iodic oil and ADM)was performed in 122patients with unresectable liver metastases.Results An overall response rate(CR PR)of all cases after the teatment was 54%.The mean survival period of 122patients was 22.2months.The0.5-,1-,2-,and 3-year survival rat e was 98.7%,80.8%,40.9%,and 10.6%,respectively.Conclusion The hepatic artery in-fusion chemotherapy and embolization is a safe and effective palliative treatment for patients with unresec table liver metastases.[
Keywords:Hepatic artery  Infusion chemotherapy  Arterial embolization  Liver m etastases
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号